China NMPA Inspection - Gansu Jiujianpeng Honeysuckle Technology Co., Ltd. - September 15, 2026

On September 15, 2026, the National Medical Products Administration (NMPA) published the results of a surprise inspection conducted on Gansu Jiujianpeng Honeysuckle Technology Co., Ltd. The investigation identified serious deficiencies in the company's production quality management system, revealing significant non-compliance with the Cosmetics Supervision and Management Regulations and the Cosmetics Production Quality Management Standards. In response to these findings, the NMPA directed the Gansu Provincial Drug Administration to initiate a formal investigation into the company’s suspected illegal activities. As a mandatory safety measure, the provincial authorities have ordered Gansu Jiujianpeng Honeysuckle Technology Co., Ltd. to immediately suspend all production and business operations. The company is required to undergo a comprehensive rectification process to address the identified violations and bring its management systems into alignment with national regulatory requirements. This action was taken to ensure public safety and maintain the integrity of the cosmetics market. The NMPA continues to oversee the case to ensure all necessary corrective actions are fully implemented before any resumption of activity is considered.